Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin for Primary Prevention in Type 2 Diabetes
NCT00886574Phase 4Unknown
- Sponsor
- Hanyang University
- Start
- Apr 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in type 2 diabetes mellitus (T2DM), sponsored by Hanyang University. Status: unknown.
02
Drugs
cilostazol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00886574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886574.